Table 1.
Patients demographic and tumor characteristics
| % | ||
|---|---|---|
| Total, n | 73 | |
| Age, years | 62.2±10.8 (42-83) | |
| BMI | 29.9±6.8 (16-45) | |
| Race, n | ||
| White | 61 | 83.6 |
| African American | 6 | 8.2 |
| Hispanic | 3 | 4.1 |
| Native American | 1 | 1.4 |
| Unknown | 2 | 2.7 |
| Clinical stage, n | ||
| I | 55 | 75.3 |
| II | 18 | 24.7 |
| Lymph node, n | ||
| Negative | 59 | 80.8 |
| Positive | 11 | 15.1 |
| Unknown | 3 | 4.1 |
| Histology grade, n | ||
| 1 | 16 | 21.9 |
| 2 | 32 | 43.8 |
| 3 | 25 | 34.2 |
| Subtype, n | ||
| Luminal A | 45 | 61.6 |
| Luminal B | 10 | 13.7 |
| HER2+ | 1 | 1.4 |
| Triple Negative | 16 | 21.9 |
| Unknown | 1 | 1.4 |
| Time after biopsy, n | ||
| <15 days | 8 | 11.0 |
| 16-30 days | 33 | 45.2 |
| >31 days | 32 | 43.8 |
| Comorbidity, n | ||
| Cardiovascular | 22 | 30.1 |
| Endocrine/metabolic | 26 | 35.6 |
| Gynecologic | 7 | 9.6 |
| Hematologic | 5 | 6.8 |
| Hepatic | 2 | 2.7 |
| Hypertension | 36 | 49.3 |
| Inflammatory/rheumatic | 22 | 30.1 |
| Neurologic | 7 | 9.6 |
| Osteoporosis | 7 | 9.6 |
| Psychiatric | 8 | 11.0 |
| Comorbidity count, n | ||
| 0 | 10 | 13.7 |
| 1 | 22 | 30.1 |
| 2 | 19 | 26.0 |
| ≥3 | 22 | 30.1 |